X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4016) 4016
male (2920) 2920
female (2801) 2801
middle aged (2652) 2652
aged (2211) 2211
oropharyngeal neoplasms - pathology (2155) 2155
adult (1867) 1867
carcinoma, squamous cell - pathology (1675) 1675
head (1467) 1467
oncology (1361) 1361
cancer (1222) 1222
oropharyngeal cancer (1193) 1193
neoplasm staging (1191) 1191
squamous cell carcinoma (1167) 1167
surgery (1123) 1123
otorhinolaryngology (1114) 1114
squamous-cell carcinoma (1111) 1111
prognosis (1045) 1045
aged, 80 and over (1025) 1025
retrospective studies (947) 947
neck-cancer (921) 921
radiotherapy (870) 870
survival (760) 760
oropharyngeal neoplasms - surgery (757) 757
human papillomavirus (738) 738
head and neck cancer (700) 700
head and neck neoplasms - pathology (691) 691
mouth neoplasms - pathology (680) 680
oropharyngeal neoplasms - virology (675) 675
papillomavirus infections (656) 656
treatment outcome (656) 656
carcinoma, squamous cell - virology (650) 650
human-papillomavirus (645) 645
carcinoma, squamous cell - surgery (608) 608
carcinoma, squamous cell - mortality (581) 581
oropharyngeal neoplasms - mortality (549) 549
oropharyngeal neoplasms - radiotherapy (549) 549
follow-up studies (539) 539
care and treatment (531) 531
chemotherapy (517) 517
oropharyngeal neoplasms - therapy (511) 511
analysis (501) 501
risk factors (474) 474
dentistry, oral surgery & medicine (472) 472
carcinoma, squamous cell - therapy (470) 470
carcinoma, squamous cell - radiotherapy (466) 466
neck (464) 464
survival rate (455) 455
tumors (441) 441
hpv (439) 439
immunohistochemistry (435) 435
disease-free survival (434) 434
lymphatic metastasis (408) 408
survival analysis (405) 405
oropharynx (399) 399
papillomavirus infections - complications (389) 389
radiology, nuclear medicine & medical imaging (389) 389
combined modality therapy (385) 385
radiation-therapy (384) 384
papillomavirus infections - virology (376) 376
prospective studies (346) 346
oropharyngeal neoplasms - diagnosis (344) 344
research (342) 342
pathology (339) 339
carcinoma (327) 327
squamous cell carcinoma of head and neck (327) 327
hematology, oncology and palliative medicine (320) 320
metastasis (319) 319
head and neck neoplasms - virology (314) 314
p16 (303) 303
oropharyngeal carcinoma (293) 293
carcinoma, squamous cell - secondary (289) 289
patients (288) 288
health aspects (287) 287
mouth neoplasms - surgery (283) 283
chemoradiotherapy (280) 280
medicine & public health (280) 280
expression (276) 276
radiotherapy dosage (273) 273
papillomaviridae - isolation & purification (271) 271
throat cancer (270) 270
carcinoma, squamous cell - genetics (268) 268
radiation (268) 268
cohort studies (265) 265
papillomavirus infections - pathology (263) 263
carcinoma, squamous cell - diagnosis (260) 260
diagnosis (259) 259
carcinoma, squamous cell - metabolism (258) 258
neck dissection (258) 258
kaplan-meier estimate (246) 246
laryngeal neoplasms - pathology (246) 246
lymph nodes - pathology (246) 246
risk (242) 242
radiation therapy (239) 239
oropharyngeal neoplasms - genetics (235) 235
prevalence (233) 233
head and neck neoplasms - mortality (231) 231
hypopharyngeal neoplasms - pathology (229) 229
oral cancer (229) 229
dentistry (228) 228
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3857) 3857
German (162) 162
French (67) 67
Russian (33) 33
Spanish (28) 28
Japanese (27) 27
Italian (20) 20
Chinese (10) 10
Polish (10) 10
Portuguese (9) 9
Dutch (4) 4
Czech (2) 2
Danish (2) 2
Hebrew (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 9, pp. 1566 - 1575
BACKGROUND Human papillomavirus (HPV) is a well‐established prognostic marker for oropharyngeal squamous cell cancer (OPSCC). Because of the limited numbers of... 
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | UNITED-STATES | POSITIVE HEAD | IN-SITU HYBRIDIZATION | IMPROVED SURVIVAL | TRIAL | NASOPHARYNGEAL CARCINOMA | HPV STATUS | THERAPY | ONCOLOGY | IMMUNOHISTOCHEMISTRY | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 291 - 298
Purpose To update the Memorial Sloan-Kettering Cancer Center’s experience with intensity-modulated radiotherapy (IMRT) in the treatment of oropharyngeal cancer... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck cancer | Dysphagia | IMRT | Xerostomia | Oropharyngeal cancer | HEAD | CHEMORADIOTHERAPY | NECK-CANCER | RADIATION-THERAPY | SALIVARY FUNCTION | IMPACT | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Pharyngeal Neoplasms - radiotherapy | Follow-Up Studies | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Palate, Soft | Male | Oropharyngeal Neoplasms - pathology | Pharyngeal Neoplasms - drug therapy | Tongue Neoplasms - drug therapy | Incidence | New York City | Palatal Neoplasms - mortality | Treatment Failure | Aged, 80 and over | Adult | Female | Xerostomia - epidemiology | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Tongue Neoplasms - mortality | Tonsillar Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Palatal Neoplasms - radiotherapy | Deglutition Disorders - epidemiology | Palatal Neoplasms - pathology | Oropharyngeal Neoplasms - radiotherapy | Cancer Care Facilities | Tonsillar Neoplasms - mortality | Tongue Neoplasms - pathology | Pharyngeal Neoplasms - mortality | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - drug therapy | Pharyngeal Neoplasms - pathology | Aged | Palatal Neoplasms - drug therapy | Neoplasm Staging | Radiotherapy, Intensity-Modulated | Care and treatment | Throat cancer | Radiotherapy | Nuclear radiation | Cancer | PATIENTS | NEOPLASMS | FAILURES | METASTASES | PLATINUM | RADIATION DOSES | LYMPHATIC SYSTEM | CHEMOTHERAPY | PLANNING | PHARYNX | TONGUE | WOMEN | MEN | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1078 - 1085
Purpose To compare the temporal lymph node (LN) regression and regional control (RC) after primary chemoradiation therapy/radiation therapy in human... 
Radiology | Hematology, Oncology and Palliative Medicine | METASTASIS | ONCOLOGY | DISSECTION | OROPHARYNGEAL CANCER | LYMPH-NODES | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Lymph Nodes - pathology | Hypopharyngeal Neoplasms - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Laryngeal Neoplasms - pathology | Lymph Nodes - radiation effects | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Papillomavirus Infections - virology | Remission Induction - methods | Oropharyngeal Neoplasms - drug therapy | Laryngeal Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Organ Size | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Lymph Nodes - virology | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Head and Neck Neoplasms - surgery | Cohort Studies | Laryngeal Neoplasms - virology | Neck Dissection | Sects | Care and treatment | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | HEAD | MULTIVARIATE ANALYSIS | NEOPLASMS | LYMPH NODES | POSITRON COMPUTED TOMOGRAPHY | CHARGES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LARYNX | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1360 - 1368
Purpose The aim of this study was to investigate prospectively the weekly volume changes in the target volumes and organs at risk and the resulting dosimetric... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Volume changes | Chemo-IMRT | Dosimetric changes | SYSTEM | DELINEATION | IMRT | ONCOLOGY | GUIDELINES | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Prospective Studies | Humans | Oropharyngeal Neoplasms - diagnostic imaging | Spinal Cord - radiation effects | Laryngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Time Factors | Laryngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Brain Stem - radiation effects | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - drug therapy | Parotid Gland - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Head and Neck Neoplasms - pathology | Radiography | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Parotid Gland - radiation effects | Hypopharyngeal Neoplasms - pathology | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Hypopharyngeal Neoplasms - diagnostic imaging | Care and treatment | Chemotherapy | Oncology, Experimental | Radiation | Research | Radiotherapy | Cancer | TOMOGRAPHY | HEAD | DIAGNOSTIC TECHNIQUES | NEOPLASMS | RADIATION DOSES | MEDICINE | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | CAT SCANNING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | BODY | COMBINED THERAPY | RADIOLOGY
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2014, Volume 89, Issue 1, pp. 13 - 20
Purpose To test whether altered radiation fractionation schemes (hyperfractionation [HFX], accelerated fractionation, continuous [AFX-C], and accelerated... 
Radiology | Hematology, Oncology and Palliative Medicine | THERAPY | EFFICACY | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | TERM-FOLLOW-UP | ACCELERATED RADIOTHERAPY | STANDARD FRACTIONATION | RISK | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | HYPERFRACTIONATION | STRATEGIES | Laryngeal Neoplasms - radiotherapy | Confidence Intervals | Carcinoma, Squamous Cell - pathology | Humans | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - radiotherapy | Cause of Death | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Time Factors | Treatment Failure | Mouth Neoplasms - radiotherapy | Enteral Nutrition - statistics & numerical data | Tongue Neoplasms - radiotherapy | Oropharyngeal Neoplasms - radiotherapy | Tongue Neoplasms - pathology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Dose Fractionation, Radiation | Hypopharyngeal Neoplasms - pathology | Mouth Neoplasms - pathology | Radiation Injuries - pathology | Head and Neck Neoplasms - mortality | Sects | Nuclear radiation | Cancer | Index Medicus | TONGUE | HEAD | PATIENTS | FRACTIONATED IRRADIATION | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | FEEDING | TOXICITY | NECK | COMPARATIVE EVALUATIONS | HAZARDS
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 67, pp. 174 - 182
Abstract Aim The aim is to evaluate the impact of cisplatin dose modification on outcomes of human papillomavirus (HPV)-related (HPV+) and HPV-unrelated (HPV−)... 
Hematology, Oncology and Palliative Medicine | Head and neck cancer | Human papillomavirus | Survival | Chemoradiotherapy | Cisplatin | THERAPY | ONCOLOGY | OROPHARYNGEAL CANCER | RADIOTHERAPY | EXPRESSION | Oropharyngeal Neoplasms - therapy | Head and Neck Neoplasms - virology | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Case-Control Studies | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Aged, 80 and over | Adult | Female | Retrospective Studies | Papillomavirus Infections - complications | Head and Neck Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - complications | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Carcinoma, Squamous Cell - complications | Hypopharyngeal Neoplasms - pathology | Radiotherapy, Conformal | Head and Neck Neoplasms - complications | Aged | Hypopharyngeal Neoplasms - complications | Neoplasm Staging | Laryngeal Neoplasms - complications | Laryngeal Neoplasms - virology | Radiotherapy, Intensity-Modulated | Papillomaviruses | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents | Papillomavirus infections
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 276 - 283
Purpose To report atypical clinical behavior observed in human papillomavirus (HPV)–related oropharyngeal carcinoma (OPC) treated with radiotherapy. Methods... 
Radiology | Hematology, Oncology and Palliative Medicine | Distant metastasis | Clinical characteristics | Human papillomavirus | Oropharyngeal carcinoma | Second primary | HEAD | FIELD CANCERIZATION | LOWER GENITAL-TRACT | CERVICAL-CARCINOMA | METASTASES | HUMAN-PAPILLOMAVIRUS DNA | NECK-CANCER | CARCINOGENESIS | ONCOLOGY | INFECTION | ASSOCIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Smoking - adverse effects | Head and Neck Neoplasms - virology | Age Factors | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | DNA, Viral - isolation & purification | Male | Oropharyngeal Neoplasms - pathology | Neoplasms, Multiple Primary - radiotherapy | Carcinoma, Squamous Cell - radiotherapy | Neoplasms, Second Primary - radiotherapy | Human papillomavirus 16 - isolation & purification | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Aged, 80 and over | Adult | Female | Mouth Neoplasms - radiotherapy | Neoplasms, Multiple Primary - virology | Papillomavirus Infections - virology | Retrospective Studies | Papillomavirus Infections - complications | Biomarkers, Tumor - analysis | Oropharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Neoplasms, Multiple Primary - pathology | Alcohol Drinking - adverse effects | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Neoplasms, Second Primary - virology | Mouth Neoplasms - pathology | Carcinoma, Squamous Cell - secondary | Aged | Human papillomavirus 16 - genetics | Neoplasms, Second Primary - pathology | Cohort Studies | Care and treatment | Squamous cell carcinoma | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | PHARYNX | PATIENTS | ORAL CAVITY | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | MUCOUS MEMBRANES
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 01/2018, Volume 110, Issue 1, pp. 109 - 120
Background: Cancer-associated fibroblasts (CAFs) are tumor-promoting and correlate with poor survival in many cancers, which has led to their emergence as... 
CELL LUNG-CANCER | PHASE-II TRIAL | OXIDATIVE STRESS | ONCOLOGY | NAB-PACLITAXEL | ACTIVATION PROTEIN | DEPENDENT INVASION | PANCREATIC-CANCER | MONOCLONAL-ANTIBODY | DIFFERENTIATION | STROMAL CELLS | Lung Neoplasms - drug therapy | Up-Regulation | Pyrazoles - therapeutic use | Reactive Oxygen Species - metabolism | Cell Count | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Head and Neck Neoplasms - chemistry | RNA Interference | Cancer-Associated Fibroblasts - chemistry | Aged, 80 and over | NADPH Oxidases - genetics | Adenocarcinoma - chemistry | Esophageal Neoplasms - chemistry | Lung Neoplasms - chemistry | NADPH Oxidases - antagonists & inhibitors | Head and Neck Neoplasms - drug therapy | Carcinoma, Squamous Cell - chemistry | Survival Rate | Adenocarcinoma - drug therapy | Disease Progression | Phenotype | Carcinoma, Squamous Cell - drug therapy | Head and Neck Neoplasms - genetics | Mice | Neoplasm Transplantation | Carcinoma, Non-Small-Cell Lung - chemistry | Carcinoma, Squamous Cell - genetics | Colorectal Neoplasms - chemistry | Cell Transdifferentiation - genetics | Myofibroblasts - chemistry | Actins - analysis | Cell Transdifferentiation - drug effects | Adult | Female | Adenocarcinoma - genetics | Cancer-Associated Fibroblasts - physiology | Pyridines - therapeutic use | Lung Neoplasms - genetics | Myofibroblasts - pathology | Carcinoma, Non-Small-Cell Lung - genetics | NADPH Oxidases - analysis | Mouth Neoplasms - chemistry | NADPH Oxidase 4 | Cancer-Associated Fibroblasts - pathology | Animals | Esophageal Neoplasms - genetics | Mouth Neoplasms - pathology | Oropharyngeal Neoplasms - chemistry | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Colorectal Neoplasms - pathology | Esophageal Neoplasms - drug therapy
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 140 - 149
Purpose To evaluate the treatment efficacy and toxicity of postoperative simultaneous modulated accelerated radiotherapy (SMART) for patients with... 
Radiology | Hematology, Oncology and Palliative Medicine | Postoperative radiotherapy | Head-and-neck cancer | Intensity-modulated radiotherapy | IMRT | Helical tomotherapy | OF-IOWA EXPERIENCE | ORAL-CAVITY CANCERS | OROPHARYNGEAL CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | INTEGRATED BOOST SIB | TARGET COVERAGE | ONCOLOGY | LOCALLY ADVANCED HEAD | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Follow-Up Studies | Neoplasms, Squamous Cell - surgery | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Carcinoma - mortality | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Esophagitis - pathology | Radiotherapy, Intensity-Modulated - adverse effects | Laryngeal Neoplasms - pathology | Young Adult | Squamous Cell Carcinoma of Head and Neck | Neoplasms, Squamous Cell - radiotherapy | Adult | Female | Mouth Neoplasms - radiotherapy | Carcinoma - pathology | Neoplasms, Squamous Cell - pathology | Radiodermatitis - etiology | Radiodermatitis - pathology | Neoplasms, Squamous Cell - mortality | Laryngeal Neoplasms - surgery | Carcinoma - surgery | Radiotherapy, Intensity-Modulated - methods | Oropharyngeal Neoplasms - radiotherapy | Carcinoma - radiotherapy | Tumor Burden | Esophagitis - etiology | Mouth Neoplasms - mortality | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Analysis of Variance | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Mouth Neoplasms - surgery | Mouth Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Xerostomia - etiology | Head and Neck Neoplasms - surgery | Squamous cell carcinoma | Research | Radiotherapy | Oncology, Experimental | Cancer | Index Medicus | SURGERY | TOMOGRAPHY | HEAD | ORAL CAVITY | DERMATITIS | DIGESTIVE SYSTEM | METASTASES | SKIN DISEASES | MEDICINE | PHARYNX | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | RADIOLOGY | DIAGNOSTIC TECHNIQUES | NEOPLASMS | LARYNX | COMPUTERIZED TOMOGRAPHY | CT-GUIDED RADIOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | RESPIRATORY SYSTEM | CARCINOMAS | NECK | BODY | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1823 - 1830
Purpose The tumor volume has been established as a significant predictor of outcomes among patients with head-and-neck cancer undergoing radiotherapy alone.... 
Radiology | Hematology, Oncology and Palliative Medicine | Primary tumor volume | Head and neck cancer | TNM staging | Tumor recurrence | Chemoradiotherapy | Survival | HYPOPHARYNGEAL CANCER | ONCOLOGY | POSITIVE HEAD | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Oropharyngeal Neoplasms - therapy | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - mortality | Laryngeal Neoplasms - diagnostic imaging | Male | Carcinoma, Squamous Cell - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Chemoradiotherapy - methods | Head and Neck Neoplasms - diagnostic imaging | Head and Neck Neoplasms - therapy | Neoplasm Recurrence, Local | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Tumor Burden | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Radiography | Disease-Free Survival | Analysis of Variance | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Hypopharyngeal Neoplasms - diagnostic imaging | Medical colleges | Care and treatment | Nuclear radiation | Patient outcomes | Oncology, Experimental | Research | Radiotherapy | Tumors | Cancer | HEAD | PATIENTS | NEOPLASMS | FAILURES | METASTASES | LARYNX | COMPUTERIZED TOMOGRAPHY | PLANNING | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | COMBINED THERAPY | HAZARDS
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1086 - 1093
Purpose To assess the dosimetric benefit, treatment outcome, and toxicity of high-dose and extended-field intensity modulated radiation therapy (IMRT) in... 
Radiology | Hematology, Oncology and Palliative Medicine | HEAD | NASOPHARYNGEAL CARCINOMA | PROGNOSTIC-FACTORS | ONCOLOGY | NASAL-TYPE | ARC THERAPY | TOXICITY | EXPERIENCE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NECK CANCER | CHEMOTHERAPY | Organs at Risk - radiation effects | Pharyngeal Neoplasms - radiotherapy | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Pharyngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - pathology | Young Adult | Child | Radiotherapy Planning, Computer-Assisted | Lymphatic Irradiation - methods | Radiotherapy, Intensity-Modulated - mortality | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Nose Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Oropharyngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - diagnostic imaging | Pharyngeal Neoplasms - mortality | Radiography | Lymphoma, Extranodal NK-T-Cell - pathology | Parotid Gland - radiation effects | Adolescent | Organs at Risk - diagnostic imaging | Lymphoma, Extranodal NK-T-Cell - mortality | Pharyngeal Neoplasms - pathology | Xerostomia - etiology | Nasopharyngeal Neoplasms - mortality | Oropharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - mortality | Radiotherapy, Intensity-Modulated - adverse effects | Organ Sparing Treatments - methods | Nasopharyngeal Neoplasms - radiotherapy | Lymphoma, Extranodal NK-T-Cell - drug therapy | Lymphoma, Extranodal NK-T-Cell - radiotherapy | Nose Neoplasms - radiotherapy | Adult | Female | Lymphatic Irradiation - adverse effects | Retrospective Studies | Nasopharyngeal Neoplasms - drug therapy | Neck | Parotid Gland - diagnostic imaging | Neoplasm Invasiveness | Treatment Outcome | Xerostomia - prevention & control | Disease-Free Survival | Lymphoma, Extranodal NK-T-Cell - diagnostic imaging | Care and treatment | Lymphomas | Radiotherapy | Nuclear radiation | Patient outcomes | Index Medicus | LYMPHOMAS | GLANDS | LYMPH NODES | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | GY RANGE 10-100 | PLANNING
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 5, pp. 1423 - 1429
Purpose To describe the spatial distribution of local-regional recurrence (LRR) among patients treated postoperatively with intensity-modulated radiotherapy... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Intensity-modulated radiotherapy | Marginal miss | DEFINITION | IMRT | PAROTID-GLAND | PATTERNS | RADIATION-THERAPY | LYMPH-NODE LEVELS | DELINEATION | ONCOLOGY | CONFORMAL RADIOTHERAPY | SQUAMOUS-CELL CARCINOMA | TARGET VOLUME | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Radiotherapy Planning, Computer-Assisted - methods | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Carcinoma, Squamous Cell - surgery | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - radiotherapy | Laryngeal Neoplasms - pathology | Neoplasm Recurrence, Local - pathology | Neoplasm Staging - methods | Aged, 80 and over | Adult | Female | Mouth Neoplasms - radiotherapy | Radiotherapy Dosage | Laryngeal Neoplasms - surgery | Radiotherapy, Intensity-Modulated - methods | Oropharyngeal Neoplasms - radiotherapy | Positron-Emission Tomography - methods | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Mouth Neoplasms - surgery | Mouth Neoplasms - pathology | Carcinoma, Squamous Cell - secondary | Aged | Head and Neck Neoplasms - surgery | Care and treatment | Radiotherapy | Cancer | HEAD | ORAL CAVITY | NEOPLASMS | LYMPH NODES | DIGESTIVE SYSTEM | LARYNX | MEDICINE | LYMPHATIC SYSTEM | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | THERAPY | GLANDS | RESPIRATORY SYSTEM | MEDICAL RECORDS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | BODY | RADIOLOGY
Journal Article